Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing

H. K. Ho, G. Németh, Y. R. Ng, E. Pang, C. Szántai-Kis, L. Zsákai, N. Breza, Z. Greff, Z. Horváth, J. Pató, I. Szabadkai, B. Szokol, F. Baska, L. Orfi, A. Ullrich, G. Kéri, B. T. Chua

Research output: Contribution to journalArticle

10 Citations (Scopus)

Fingerprint Dive into the research topics of 'Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds